Natural History Studies: Danon Disease: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 September 2025

11 September 2025

  • curprev 19:2519:25, 11 September 2025‎ ElwoodMccurdy talk contribs‎ 5,340 bytes +5,340‎ Created page with "<br>RP-A501 is being developed for Danon Disease, a rare genetic disorder characterized by thickening and weakening of the heart muscle, often resulting in heart failure, and for male patients, frequent death during adolescence or early adulthood. Rocket is the first company demonstrating safety and efficacy data in [https://www.blogrollcenter.com/?s=clinical%20studies clinical studies] for gene therapy targeting the heart. An open-label, global Phase 2 pivotal clinical..."
Retrieved from "https://wiki.timero.com.br/index.php?title=Natural_History_Studies:_Danon_Disease"